The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
Open accessAbstract
BACKGROUND: The role of neoadjuvant chemoradiotherapy in the treatment of patients with esophageal or esophagogastric-junction cancer is not well established. We compared chemoradiotherapy followed by surgery with surgery alone in this patient population. METHODS: We randomly assigned patients with resectable tumors to receive surgery alone or weekly administration of carboplatin (doses titrated to achieve an area under the curve of 2 mg per milliliter per minute) and paclitaxel (50 mg per square meter of body-surface area) for 5 weeks and concurrent radiotherapy (41.4 Gy in 23 fractions, 5 days per week), followed by surgery. RESULTS: From March 2004 through December 2008, we enrolled 368 patients, 366 of whom were included in the analysis: 275 (75%) had adenocarcinoma, 84 (23%) had squamous-cell carcinoma, and 7 (2%) had large-cell undifferentiated carcinoma. Of the 366 patients, 178 were randomly assigned to chemoradiotherapy followed by surgery, and 188 to surgery alone. The most common major hematologic toxic effects in the chemoradiotherapy-surgery group were leukopenia (6%) and neutropenia (2%); the most common major nonhematologic toxic effects were anorexia (5%) and fatigue (3%). Complete resection with no tumor within 1 mm of the resection margins (R0) was achieved in 92% of patients in the chemoradiotherapy-surgery group versus 69% in the surgery group (P<0.001). A pathological complete response was achieved in 47 of 161 patients (29%) who underwent resection after chemoradiotherapy. Postoperative complications were similar in the two treatment groups, and in-hospital mortality was 4% in both. Median overall survival was 49.4 months in the chemoradiotherapy-surgery group versus 24.0 months in the surgery group. Overall survival was significantly better in the chemoradiotherapy-surgery group (hazard ratio, 0.657; 95% confidence interval, 0.495 to 0.871; P=0.003). CONCLUSIONS: Preoperative chemoradiotherapy improved survival among patients with potentially curable esophageal or esophagogastric-junction cancer. The regimen was associated with acceptable adverse-event rates. (Funded by the Dutch Cancer Foundation [KWF Kankerbestrijding]; Netherlands Trial Register number, NTR487.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
TNM Classification of Malignant Tumours
(1987) · Springer eBooks · doi:10.1007/978-3-642-82982-6 · Cited by 16,049
Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer
Cunningham, D., Allum, W. H., Stenning, S. P., Thompson, J. N., Van de Velde, C. J. H., Nicolson, M., Scarffe, J. H., Lofts, F. J., Falk, S. J., Iveson, T. J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055531 · Cited by 6,334
TROTTI, A., COLEVAS, A., SETSER, A., RUSCH, V, JAQUES, D., BUDACH, V, LANGER, C., MURPHY, B., CUMBERLIN, R., & COLEMAN, C. (2003) · Seminars in Radiation Oncology · doi:10.1016/s1053-4296(03)00031-6 · Cited by 2,569
Cancer burden in the year 2000. The global picture
Parkin, D. M., Bray, F. I., & Devesa, S. S. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00267-2 · Cited by 2,169
Changing patterns in the incidence of esophageal and gastric carcinoma in the United States
Devesa, S. S., Blot, W. J., & Fraumeni, J. F. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19981115)83:10<2049::aid-cncr1>3.0.co;2-2 · Cited by 2,115
Ychou, M., Boige, V., Pignon, J.-P., Conroy, T., Bouché, O., Lebreton, G., Ducourtieux, M., Bedenne, L., Fabre, J.-M., Saint-Aubert, B., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.0597 · Cited by 2,086
Mandard, A.-M., Dalibard, F., Mandard, J.-C., Marnay, J., Henry-Amar, M., Petiot, J.-F., Roussel, A., Jacob, J.-H., Segol, P., Samama, G., et al. (1994) · Cancer · doi:10.1002/1097-0142(19940601)73:11<2680::aid-cncr2820731105>3.0.co;2-c · Cited by 2,044
A Comparison of Multimodal Therapy and Surgery for Esophageal Adenocarcinoma
Walsh, T. N., Noonan, N., Hollywood, D., Kelly, A., Keeling, N., & Hennessy, T. P. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608153350702 · Cited by 1,950
Bosset, J.-F., Gignoux, M., Triboulet, J.-P., Tiret, E., Mantion, G., Elias, D., Lozach, P., Ollier, J.-C., Pavy, J.-J., Mercier, M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707173370304 · Cited by 1,376
Tepper, J., Krasna, M. J., Niedzwiecki, D., Hollis, D., Reed, C. E., Goldberg, R., Kiel, K., Willett, C., Sugarbaker, D., & Mayer, R. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.9593 · Cited by 1,352
Chemotherapy Followed by Surgery Compared with Surgery Alone for Localized Esophageal Cancer
Kelsen, D. P., Ginsberg, R., Pajak, T. F., Sheahan, D. G., Gunderson, L., Mortimer, J., Estes, N., Haller, D. G., Ajani, J., Kocha, W., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199812313392704 · Cited by 1,343
Urba, S. G., Orringer, M. B., Turrisi, A., Iannettoni, M., Forastiere, A., & Strawderman, M. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.305 · Cited by 1,266
International Union against Cancer
(1959) · Journal of the Faculty of Radiologists · doi:10.1016/s0368-2242(59)80060-9 · Cited by 1,220
Stahl, M., Walz, M. K., Stuschke, M., Lehmann, N., Meyer, H.-J., Riera-Knorrenschild, J., Langer, P., Engenhart-Cabillic, R., Bitzer, M., Königsrainer, A., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.0506 · Cited by 948
Burmeister, B. H., Smithers, B. M., Gebski, V., Fitzgerald, L., Simes, R. J., Devitt, P., Ackland, S., Gotley, D. C., Joseph, D., Millar, J., et al. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70288-6 · Cited by 926
International union against cancer
Sherman, C. (1988) · Journal of Cancer Education · doi:10.1080/08858198809527918 · Cited by 641
Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis
Fiorica, F., Di Bona, D., Schepis, F., Licata, A., Shahied, L., Venturi, A., Falchi, A. M., Craxì, A., & Cammà, C. (2004) · Gut · doi:10.1136/gut.2003.025080 · Cited by 539
Chirieac, L. R., Swisher, S. G., Ajani, J. A., Komaki, R. R., Correa, A. M., Morris, J. S., Roth, J. A., Rashid, A., Hamilton, S. R., & Wu, T. (2005) · Cancer · doi:10.1002/cncr.20916 · Cited by 495
Parkin, D. M., Bray, F. I., & Devesa, S. S. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00739-6 · Cited by 479
Lee, J.-L., Park, S. I., Kim, S.-B., Jung, H.-Y., Lee, G. H., Kim, J.-H., Song, H.-Y., Cho, K.-J., Kim, W.-K., Lee, J.-S., et al. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh219 · Cited by 342
Preoperative chemotherapy for resectable thoracic esophageal cancer
Kidane, B., Coughlin, S., Vogt, K., & Malthaner, R. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001556.pub3 · Cited by 237
van Heijl, M., van Lanschot, J., Koppert, L. B., Henegouwen, M. I. V. B., Müller, K., Steyerberg, E. W., van Dekken, H., Wijnhoven, B. P. L., Tilanus, H., Richel, D. J., et al. (2008) · BMC Surgery · doi:10.1186/1471-2482-8-21 · Cited by 137
Self-citationvan Meerten, E., Müller, K., Tilanus, H. W., Siersema, P. D., Eijkenboom, W. M. H., van Dekken, H., Tran, T. C. K., & van der Gaast, A. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603134 · Cited by 125
Self-citation
Cited by
Al-Batran, S.-E., Homann, N., Pauligk, C., Goetze, T. O., Meiler, J., Kasper, S., Kopp, H.-G., Mayer, F., Haag, G. M., Luley, K., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32557-1 · Cited by 2,648
Shapiro, J., van Lanschot, J. J. B., Hulshof, M. C. C. M., van Hagen, P., van Berge Henegouwen, M. I., Wijnhoven, B. P. L., van Laarhoven, H. W. M., Nieuwenhuijzen, G. A. P., Hospers, G. A. P., Bonenkamp, J. J., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00040-6 · Cited by 2,565
Self-citationCurrent treatment and recent progress in gastric cancer
Joshi, S. S., & Badgwell, B. D. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21657 · Cited by 1,677
Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis
Cools-Lartigue, J., Spicer, J., McDonald, B., Gowing, S., Chow, S., Giannias, B., Bourdeau, F., Kubes, P., & Ferri, L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67484 · Cited by 1,395
Rustgi, A. K., & El-Serag, H. B. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1314530 · Cited by 1,243
Metadata
- Authors
- van Hagen, P., Hulshof, M. C. C. M., van Lanschot, J. J. B., Steyerberg, E. W., Henegouwen, M. I. V. B., Wijnhoven, B. P. L., Richel, D. J., Nieuwenhuijzen, G. A. P., Hospers, G. A. P., Bonenkamp, J. J., Cuesta, M. A., Blaisse, R. J. B., Busch, O. R. C., ten Kate, F. J. W., Creemers, G.-J., Punt, C. J. A., Plukker, J. T. M., Verheul, H. M. W., Bilgen, E. J. S., van Dekken, H., van der Sangen, M. J. C., Rozema, T., Biermann, K., Beukema, J. C., Piet, A. H. M., van Rij, C. M., Reinders, J. G., Tilanus, H. W., & van der Gaast, A.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2012-05-31
- Volume
- 366
- Issue
- 22
- Pages
- 2074-2084
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2154444715
- Cited by
- 5,521
- References
- 24
- FWCI
- 270.88
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.